iShares Biotechnology ETF (NASDAQ:IBB) Holdings Decreased by Johns Hopkins University

Johns Hopkins University lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 229,449 shares of the financial services provider’s stock after selling 183 shares during the quarter. iShares Biotechnology ETF comprises about 1.3% of Johns Hopkins University’s portfolio, making the stock its 11th biggest holding. Johns Hopkins University’s holdings in iShares Biotechnology ETF were worth $31,494,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Corient Private Wealth LLC lifted its stake in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after acquiring an additional 841 shares during the period. Mmbg Investment Advisors CO. raised its holdings in iShares Biotechnology ETF by 0.6% during the fourth quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock worth $10,671,000 after purchasing an additional 495 shares in the last quarter. Oppenheimer & Co. Inc. lifted its position in iShares Biotechnology ETF by 7.6% in the first quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock worth $4,905,000 after purchasing an additional 2,532 shares during the period. Chemistry Wealth Management LLC boosted its stake in iShares Biotechnology ETF by 20.6% during the 1st quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock valued at $488,000 after purchasing an additional 609 shares in the last quarter. Finally, Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF during the 1st quarter valued at $27,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $147.81 on Monday. The stock’s fifty day moving average is $145.10 and its 200-day moving average is $138.27. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.